Filing Details
- Accession Number:
- 0001209191-17-028224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-26 17:02:14
- Reporting Period:
- 2017-04-24
- Filing Date:
- 2017-04-26
- Accepted Time:
- 2017-04-26 17:02:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238362 | John Mendlein | 3545 John Hopkins Court, Suite 250 San Diego CA 92121 | Ceo And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-24 | 124 | $3.00 | 327,647 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 21, 2016.
Billionaire Hedge Funds
